Millennium Management
TPTX

Millennium Management’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Millennium Management’s Portfolio TPTX Stock Details TPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-160,800
Closed -$12.1M – 7816
2022
Q2 		$12.1M Buy
+160,800
New +$7.15M 0.01% 1806

Millennium Management's TPTX Position: Q3 2022 in Review

Millennium Management sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q3 2022, closing a stake of 610,489 shares — an estimated $45.9M sold.

Millennium Management first reported a position in TPTX in Q3 2019 and held it in 11 quarters. The position peaked at $45.9M in Q2 2022. 0 funds tracked by Wall St. Rank hold TPTX as of Q3 2022.

  • Millennium Management reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Millennium Management sold 610,489 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $45.9M.
  • Millennium Management first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q3 2019 and held it in 11 quarters.
  • Millennium Management's Turning Point Therapeutics, Inc. Common Stock position peaked at $45.9M in Q2 2022.
  • 0 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Millennium Management's 13F filing for Q3 2022, filed 14 Nov 2022.